
Globus Medical Inc
NYSE:GMED

Intrinsic Value
The intrinsic value of one
GMED
stock under the Base Case scenario is
86.46
USD.
Compared to the current market price of 72.46 USD,
Globus Medical Inc
is
Undervalued by 16%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Globus Medical Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Globus Medical Inc
Balance Sheet Decomposition
Globus Medical Inc
Current Assets | 2.2B |
Cash & Short-Term Investments | 890.1m |
Receivables | 578.3m |
Other Current Assets | 708.9m |
Non-Current Assets | 3.1B |
Long-Term Investments | 66.1m |
PP&E | 612.1m |
Intangibles | 2.2B |
Other Non-Current Assets | 168.8m |
Free Cash Flow Analysis
Globus Medical Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Globus Medical Inc
Revenue
|
2.5B
USD
|
Cost of Revenue
|
-1B
USD
|
Gross Profit
|
1.5B
USD
|
Operating Expenses
|
-1.3B
USD
|
Operating Income
|
219.7m
USD
|
Other Expenses
|
-116.7m
USD
|
Net Income
|
103m
USD
|
GMED Profitability Score
Profitability Due Diligence
Globus Medical Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Score
Globus Medical Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
GMED Solvency Score
Solvency Due Diligence
Globus Medical Inc's solvency score is 84/100. The higher the solvency score, the more solvent the company is.

Score
Globus Medical Inc's solvency score is 84/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GMED Price Targets Summary
Globus Medical Inc
According to Wall Street analysts, the average 1-year price target for
GMED
is 99.41 USD
with a low forecast of 80.8 USD and a high forecast of 120.75 USD.
Dividends
Current shareholder yield for GMED is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
GMED
stock under the Base Case scenario is
86.46
USD.
Compared to the current market price of 72.46 USD,
Globus Medical Inc
is
Undervalued by 16%.